These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35211125)

  • 21. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.
    Skerry CM; Mahon BP
    Clin Vaccine Immunol; 2011 Feb; 18(2):187-93. PubMed ID: 21147936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy.
    da Silva Antunes R; Soldevila F; Pomaznoy M; Babor M; Bennett J; Tian Y; Khalil N; Qian Y; Mandava A; Scheuermann RH; Cortese M; Pulendran B; Petro CD; Gilkes AP; Purcell LA; Sette A; Peters B
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33690224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
    Auderset F; Ballester M; Mastelic-Gavillet B; Fontannaz P; Chabaud-Riou M; Reveneau N; Garinot M; Mistretta N; Liu Y; Lambert PH; Ochs M; Siegrist CA
    Front Immunol; 2019; 10():1520. PubMed ID: 31333656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.
    Dunne A; Mielke LA; Allen AC; Sutton CE; Higgs R; Cunningham CC; Higgins SC; Mills KH
    Mucosal Immunol; 2015 May; 8(3):607-17. PubMed ID: 25315966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
    Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
    Front Immunol; 2022; 13():878832. PubMed ID: 35493458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents.
    Paradowska-Stankiewicz I; Rumik A; Bogusz J; Zbrzeźniak J; Rastawicki W; Śmietańska K; Vargas-Zambrano JC; Macina D
    Vaccine; 2021 Oct; 39(41):6067-6073. PubMed ID: 34511302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T
    Allen AC; Wilk MM; Misiak A; Borkner L; Murphy D; Mills KHG
    Mucosal Immunol; 2018 Nov; 11(6):1763-1776. PubMed ID: 30127384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
    Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Pertussis Vaccines: A Need and a Challenge.
    Hozbor D
    Adv Exp Med Biol; 2019; 1183():115-126. PubMed ID: 31432399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of pertussis-specific effector memory T cells in preschool children.
    de Rond L; Schure RM; Öztürk K; Berbers G; Sanders E; van Twillert I; Carollo M; Mascart F; Ausiello CM; van Els CA; Smits K; Buisman AM
    Clin Vaccine Immunol; 2015 May; 22(5):561-9. PubMed ID: 25787136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
    Cornford-Nairns R; Daggard G; Mukkur T
    J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody Specificity Following a Recent
    Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
    Front Immunol; 2019; 10():1364. PubMed ID: 31275314
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of evidence supporting a role of IFN-β and TGF-β in differential polarization of Bordetella pertussis specific-T cell responses.
    da Silva Antunes R; Quiambao LG; Soldevila F; Sutherland A; Peters B; Sette A
    Cytokine; 2021 Jan; 137():155313. PubMed ID: 33002739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions.
    Kim AR; Sette A; da Silva Antunes R
    Expert Rev Vaccines; 2024; 23(1):705-714. PubMed ID: 39037200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of a
    da Silva Antunes R; Quiambao LG; Sutherland A; Soldevila F; Dhanda SK; Armstrong SK; Brickman TJ; Merkel T; Peters B; Sette A
    J Immunol Res; 2020; 2020():8202067. PubMed ID: 32322598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.
    Redhead K; Watkins J; Barnard A; Mills KH
    Infect Immun; 1993 Aug; 61(8):3190-8. PubMed ID: 8335349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
    van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
    Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.